Phase 1
Completed N=58
Persistence-Targeted Smoking Cessation
Source: ClinicalTrials.gov NCT01654107 ↗Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Sep 2015
Primary outcomePrimary: 7-day Point Prevalence Abstinence — 4; 1 participants
Summary
The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 7-day Point Prevalence Abstinence |
4; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Must be between 18 - 64 years old
- Must smoke at least 10 cigarettes per day for past 6-months
- Expired breath carbon monoxide (CO) > 7
- Must have a working cellular phone
Exclusion Criteria
- Must not be currently receiving tobacco dependence treatment counseling
- Must not currently be taking varenicline, bupropion, or any nicotine preparations (gum, lozenge, patch, spray, inhaler)
- Must have no contraindications to using nicotine lozenge
Data sourced from ClinicalTrials.gov (NCT01654107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.